Healthtech Hub

We support visionary founders with long-term capital, scale-up expertise, and unparalleled ecosystem access.

Years in healthtech investing

1,000+

Healthtech startups mapped across Europe

$3bn

Follow on funding raised by AlbionVC backed companies

+1.4m

Patients treated to date with continued strong growth

What we do

Building the most connected healthtech ecosystem.

HealthTech Investing

Partners to early-stage healthcare technology companies since 2004. From digital care and clinical decision support to AI-driven drug discovery, we back visionary founders transforming European healthcare.

HealthTech Breakfast Club

Uniting the European healthtech ecosystem. Quarterly investor meetups, annual networking events and conference briefings bringing together founders, operators, and VC investors.

European HealthTech Market Map

Our annual market map charts over 1,000 high-growth startups and scaleups across digital care and digital pharma transforming European healthcare.

Harley Street Health District

A strategic partnership connecting London’s world-renowned health district with the UK’s leading healthtech startups, creating a new blueprint for rapid adoption and innovation.

Market intelligence

Research & Expertise

The AlbionVC healthcare team regularly publishes deep dives on the evolving European healthcare landscape, covering trends driven by founders, emerging technologies, macro forces, and the challenges facing national health systems. Their analysis highlights where meaningful innovation is happening and where the most promising opportunities are emerging.

European HealthTech Market Map 2025

LLMs streamlining clinical workflows — from ambient listening to back office automation
Virtual-first care entering as a new segment — unified, condition-specific care pathways
AI accelerating drug discovery with 25 new startups targeting previously untreatable diseases

View Map

Community

HealthTech Breakfast Club

On a mission to unite the European healthtech ecosystem. The club brings together founders, operators and investors to learn, up-skill, and share insights about emerging industry trends.

Learn more

Partnership

Harley Street Health District

Connecting London’s world-renowned health district with the UK’s leading healthtech startups. Startups gain a structured pathway to co-develop, pilot, and scale innovations in real-world clinical settings.

Learn more

“We’re not just funding companies, we’re connecting them to the world-renowned expertise of Harley Street Health District.”
Andrew Elder, Partner, AlbionVC

Our companies

Partnering with founders building the future of health & science

Achilles Therapeutics

IPO | Biopharmaceutical company developing precision T cell therapies

➔

Apollo Therapeutics

Growth | Biopharmaceutical company advancing a robust pipeline of potentially transformative therapeutic programs

➔

Arecor

Growth | Biopharmaceutical company developing future medicines from existing therapies

➔

Aridhia

Early Stage | Collaborative healthcare research platform

➔

CS Genetics

Early Stage | Disruptive platform for single-cell genomics which leverages instrument-free, solution-phase chemical biology.Arecor

➔

Dexela

Exited | X-ray imaging for early detection of breast cancer

Dysis

Exited | Medical device company specialising in imaging for the detection of cancerous & pre-cancerous lesions

➔

Evaro

Growth | Online pharmacy that allows businesses to embed its services within their own website

➔

EpilepsyGTx

Early Stage | Biotechnology company developing of cutting-edge gene therapies to treat focal refractory epilepsy

➔

Epsilogen

Early Stage | Immuno-oncology company targeting cancer with the IgE class of antibodies

➔

Exco Intouch

Exited | Digital engagement and data capture solutions for clinical research and healthcare programs

Healios

Early Stage | Digital platform offering mental health services for young adults and children

➔

Locum’s Nest

Exited | Platform that connects healthcare professionals and vacancies

➔

MyMeds&Me

Exited | SaaS solution for capture, management and processing of adverse event, drug safety and product complaint data

Meira GTX

IPO | Vertically integrated, clinical stage gene therapy company

➔

NovalGen

Early Stage | Immuno-oncology company developing breakthrough bispecific therapies that can safely harness the immune system to fight cancer

➔

Neurofenix

Exited | Digital rehabilitation platform

➔

NuvoAir

Early Stage | Digital respiratory care platform

➔

Oviva

Growth | Europe’s leading weight loss management platform

➔

Orchard Therapeutics

IPO | Biotechnology company bringing transformative gene therapies to patients with serious and life-threatening orphan diseases

➔

Pando

Exited | Communications platform for healthcare professionals

➔

PeakData

Early Stage | Global AI customer targeting platform

➔

Peppy

Growth | Employee healthcare benefits platform

➔

Proveca

Growth | Medicines designed specifically for children

➔

Scripta Therapeutics

Early Stage | Modulating transcription factor activity to restore health

➔

uMed

Early Stage | Connectivity to power prospective research at scale

➔

uMotif

Exited | Patient-first data capture and decentralised clinical trials

➔

Quell Therapeutics

Growth | A clinical stage company transforming lives in immune mediated disease

➔

Building the future of European healthcare?

Whether you’re a founder, investor or ecosystem partner — we’d love to connect.

Stay in the know

Join our community